SE392616B - Forfarande for framstellning av kinazolinonforeningar - Google Patents

Forfarande for framstellning av kinazolinonforeningar

Info

Publication number
SE392616B
SE392616B SE739172A SE739172A SE392616B SE 392616 B SE392616 B SE 392616B SE 739172 A SE739172 A SE 739172A SE 739172 A SE739172 A SE 739172A SE 392616 B SE392616 B SE 392616B
Authority
SE
Sweden
Prior art keywords
kinazolinone
compounds
procedure
preparation
kinazolinone compounds
Prior art date
Application number
SE739172A
Other languages
English (en)
Inventor
K Ishizumi
K Mori
M Yamamoto
M Koshiba
S Inaba
H Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4781271A external-priority patent/JPS50670B1/ja
Priority claimed from JP4839771A external-priority patent/JPS4929195B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE392616B publication Critical patent/SE392616B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SE739172A 1971-06-29 1972-06-06 Forfarande for framstellning av kinazolinonforeningar SE392616B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4781271A JPS50670B1 (sv) 1971-06-29 1971-06-29
JP4839771A JPS4929195B1 (sv) 1971-06-30 1971-06-30

Publications (1)

Publication Number Publication Date
SE392616B true SE392616B (sv) 1977-04-04

Family

ID=26387992

Family Applications (1)

Application Number Title Priority Date Filing Date
SE739172A SE392616B (sv) 1971-06-29 1972-06-06 Forfarande for framstellning av kinazolinonforeningar

Country Status (5)

Country Link
CA (1) CA956636A (sv)
CH (1) CH574940A5 (sv)
DK (1) DK132624C (sv)
NL (1) NL7209078A (sv)
SE (1) SE392616B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631283A (en) * 1982-09-30 1986-12-23 Ortho Pharmaceutical Corporation Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids
US4490374A (en) * 1982-09-30 1984-12-25 Ortho Pharmaceutical Corporation 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use

Also Published As

Publication number Publication date
NL7209078A (sv) 1973-01-03
CA956636A (en) 1974-10-22
DK132624C (da) 1976-06-28
CH574940A5 (en) 1976-04-30
DK132624B (da) 1976-01-12

Similar Documents

Publication Publication Date Title
SE385891B (sv) Forfarande for framstellning av bensopyranforeningar
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE387948B (sv) Forfarande for framstellning av tiofen